Showing results (1-10 of 159) with videos related to
Sort By:
Pageof 16
Acta Haematologica|June 21, 2008
BCR-ABL in chronic myelogenous leukemia--how does it work?John M Goldman, Junia V MeloExperimental Hematology|October 31, 2003
Comparative gene expression profile of chronic myeloid leukemia cells innately resistant to imatinib mesylateAlex J Tipping, Michael W Deininger, John M Goldman, et al.Blood|February 28, 2002
Overexpression of SOCS-2 in advanced stages of chronic myeloid leukemia: possible inadequacy of a negative feedback mechanismBeate Schultheis, Melina Carapeti-Marootian, Andreas Hochhaus, et al.Blood|September 8, 2005
Molecular profiling of CD34+ cells identifies low expression of CD7, along with high expression of proteinase 3 or elastase, as predictors of longer survival in patients with CMLAgnes S M Yong, Richard M Szydlo, John M Goldman, et al.Blood|June 21, 2008
Association between BMI-1 expression, acute graft-versus-host disease, and outcome following allogeneic stem cell transplantation from HLA-identical siblings in chronic myeloid leukemiaMohamad Mohty, Richard M Szydlo, Agnes S M Yong, et al.Oncotargets and Therapy|July 10, 2010
Targeted treatment of imatinib-resistant chronic myeloid leukemia: Focus on dasatinibCharles Chuah, Junia V MeloHematology. American Society of Hematology. Education Program|December 17, 2008
Novel agents in CML therapy: tyrosine kinase inhibitors and beyondJunia V Melo, Charles ChuahInternational Journal of Hematology|July 9, 2004
Biology of chronic myeloid leukemia and possible therapeutic approaches to imatinib-resistant diseaseChikashi Yoshida, Junia V MeloClinical Hematology International|February 6, 2025
How to perform a high-quality peer reviewMohamad Mohty, Junia V MeloPageof 16